← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Eolas Therapeutics, Inc.
Palm Beach Gardens, FL
$3,498,209
Total funding
2
Grants
Funding over time
peak $3M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,498,209 · 2
By mechanism
UH3$3,027,897 · 1
U01$470,312 · 1
Investigators at Eolas Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder$3,027,897
UH3 · FY2025 · DA
Orexin receptor antagonist for drug addiction and panic disorder$104,000
U01 · FY2016 · NS
Orexin receptor antagonists for drug addiction and panic disorder$91,578
U01 · FY2014 · NS
Orexin receptor antagonists for drug addiction and panic disorder$91,578
U01 · FY2015 · NS
Orexin receptor antagonists for drug addiction and panic disorder$91,578
U01 · FY2016 · NS
Orexin receptor antagonists for drug addiction and panic disorder$91,578
U01 · FY2017 · NS